The Transcription Factor SOX9 Regulates Cell Cycle and Differentiation Genes in Chondrocytic CFK2 Cells*

SOX9 is a transcription factor that is essential for chondrocyte differentiation and cartilage formation. We stably overexpressed SOX9 cDNA in the rat chondrocytic cell line CFK2. Compared with the vector control, a greater proportion of SOX9-transfected cells accumulated in the G0/G1 phase. This was associated with an increase in mRNA and protein expression of p21 cip1 , an inhibitor of cyclin-dependent kinase activity. SOX9 enhanced p21 cip1 promoter activity in a luciferase reporter assay. CFK2 cells overexpressing SOX9 became more elongated and adhesive and demonstrated a shift in cytoplasmic F-actin distribution. N-cadherin mRNA levels were elevated in the SOX9-transfected cells, and SOX9 enhanced N-cadherin promoter activity. By electrophoretic mobility shift assay, nuclear extracts of SOX9-transfected CFK2 cells specifically bound an oligonucleotide comprising an N-cadherin promoter region containing a consensus SOX9-binding motif. The transcriptional activity of SOX9 depended upon nuclear localization signals required for SOX9 nuclear entry. Differentiation of transfected CFK2 cells was accelerated as evidenced by more rapid accumulation of alkaline phosphatase activity, increased production of proteoglycans, and increased calcium accumulation, and this was associated with decreased ERK1 expression. These studies demonstrate that SOX9 alters the rate of cell cycle progression of chondrocytes and their differentiation by enhancing or inhibiting the expression of selected genes, including p21 cip1 and ERK1, and that N-cadherin is an additional direct target of this transcriptional regulator.

[1]  D. Towler,et al.  Fibroblast Growth Factor Receptor 3 Gene Transcription Is Suppressed by Cyclic Adenosine 3′,5′-Monophosphate , 1999, The Journal of Biological Chemistry.

[2]  M. Clarke,et al.  A Bipartite Nuclear Localization Signal Is Required for p53 Nuclear Import Regulated by a Carboxyl-terminal Domain* , 1999, The Journal of Biological Chemistry.

[3]  V. Lefebvre,et al.  Phosphorylation of SOX9 by Cyclic AMP-Dependent Protein Kinase A Enhances SOX9's Ability To Transactivate aCol2a1 Chondrocyte-Specific Enhancer , 2000, Molecular and Cellular Biology.

[4]  H. Kondoh,et al.  Pairing SOX off: with partners in the regulation of embryonic development. , 2000, Trends in genetics : TIG.

[5]  Su-Jae Lee,et al.  Opposing Role of Mitogen-activated Protein Kinase Subtypes, Erk-1/2 and p38, in the Regulation of Chondrogenesis of Mesenchymes* , 2000, The Journal of Biological Chemistry.

[6]  N. Tommerup,et al.  Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9 , 1994, Cell.

[7]  V. Harley,et al.  The DNA-binding specificity of SOX9 and other SOX proteins. , 1999, Nucleic acids research.

[8]  M. Pembrey,et al.  A clinical and genetic study of campomelic dysplasia. , 1995, Journal of medical genetics.

[9]  V. Lefebvre,et al.  Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[10]  Véronique Lefebvre,et al.  A new long form of Sox5 (L‐Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene , 1998, The EMBO journal.

[11]  Y. Iwamoto,et al.  A Zinc Finger Transcription Factor, αA-Crystallin Binding Protein 1, Is a Negative Regulator of the Chondrocyte-Specific Enhancer of the α1(II) Collagen Gene , 2000, Molecular and Cellular Biology.

[12]  A. Ashworth,et al.  DNA binding and bending properties of the post-meiotically expressed Sry-related protein Sox-5. , 1994, Nucleic acids research.

[13]  F. Beier,et al.  The Raf-1/MEK/ERK Pathway Regulates the Expression of the p21Cip1/Waf1 Gene in Chondrocytes* , 1999, The Journal of Biological Chemistry.

[14]  R. Cancedda,et al.  N-CAM and N-cadherin expression during in vitro chondrogenesis. , 1994, Experimental cell research.

[15]  Xiao-Fan Wang,et al.  Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 Promoter (*) , 1995, The Journal of Biological Chemistry.

[16]  F Meijlink,et al.  Prx1 and Prx2 in skeletogenesis: roles in the craniofacial region, inner ear and limbs. , 1998, Development.

[17]  B. Hancock,et al.  Activation of MYCN in a case of non-Hodgkin's lymphoma. , 1995, Leukemia & lymphoma.

[18]  J. Martín,et al.  The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. , 1995, Genes & development.

[19]  Sahar Mansour,et al.  Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.

[20]  Donald M. Bell,et al.  SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. , 1997, Developmental biology.

[21]  C. Sherr,et al.  Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.

[22]  S. Stabel,et al.  Sequence of a rat cDNA encoding the ERK1-MAP kinase. , 1992, Gene.

[23]  B. Crombrugghe,et al.  Toward understanding SOX9 function in chondrocyte differentiation. , 1998 .

[24]  D. Goltzman,et al.  Regulation of expression of the chondrocytic phenotype in a skeletal cell line (CFK2) in vitro , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  Clifford J. Tabin,et al.  Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein , 1996, Science.

[26]  Patrick P.L. Tam,et al.  SOX9 directly regulates the type-ll collagen gene , 1997, Nature Genetics.

[27]  S. Lowe,et al.  E1A signaling to p53 involves the p19(ARF) tumor suppressor. , 1998, Genes & development.

[28]  W. Woodward,et al.  N-Cadherin expression and signaling in limb mesenchymal chondrogenesis: stimulation by poly-L-lysine. , 1999, Developmental genetics.

[29]  V. Lefebvre,et al.  Chondrocyte-specific Enhancer Elements in the Col11a2Gene Resemble the Col2a1 Tissue-specific Enhancer* , 1998, The Journal of Biological Chemistry.

[30]  S. Mundlos,et al.  Heritable diseases of the skeleton. Part I: Molecular insights into skeletal development‐transcription factors and signaling pathways 1 , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  R. Laskey,et al.  Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: Identification of a class of bipartite nuclear targeting sequence , 1991, Cell.

[32]  Shin‐Sung Kang,et al.  Protein Kinase C Regulates Chondrogenesis of Mesenchymes via Mitogen-activated Protein Kinase Signaling* , 1998, The Journal of Biological Chemistry.

[33]  J. Pujol,et al.  Cell-Cycle-Dependent Expression of Transforming Growth Factor β Type I Receptor Correlates with Differential Proliferative Effects of TGFβ1in Articular Chondrocytes☆☆☆ , 1998 .

[34]  R. Tuan,et al.  Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. , 1994, Development.

[35]  M. Roussel,et al.  p53-independent functions of the p19(ARF) tumor suppressor. , 2000, Genes & development.

[36]  R. Cancedda,et al.  Regulated expression of fibronectin, laminin and related integrin receptors during the early chondrocyte differentiation. , 1997, Journal of cell science.

[37]  R. Tuan,et al.  Expression of the paired‐box genes Pax‐1 and Pax‐9 in limb skeleton development , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[38]  B. Gallie,et al.  A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity , 1993, Molecular and cellular biology.

[39]  Richard R. Behringer,et al.  Sox9 is required for cartilage formation , 1999, Nature Genetics.

[40]  Gerd Scherer,et al.  Direct Interaction of SRY-Related Protein SOX9 and Steroidogenic Factor 1 Regulates Transcription of the Human Anti-Müllerian Hormone Gene , 1998, Molecular and Cellular Biology.

[41]  P N Goodfellow,et al.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene , 1997, Molecular and cellular biology.

[42]  N. Paradies,et al.  Isolation and characterization of the promoter region of the chicken N-cadherin gene. , 1997, Gene.

[43]  R Kemler,et al.  Cadherins and tissue formation: integrating adhesion and signaling , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[44]  Nancy Y. Ip,et al.  ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF , 1991, Cell.

[45]  C. Xiao,et al.  Nuclear targeting signal recognition: a key control point in nuclear transport? , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[46]  Andy Greenfield,et al.  The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos , 1995, Nature Genetics.

[47]  R Grosschedl,et al.  Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. , 1995, Genes & development.

[48]  S. Murakami,et al.  Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  William D. Richardson,et al.  A short amino acid sequence able to specify nuclear location , 1984, Cell.